000 01231 a2200349 4500
005 20250516171508.0
264 0 _c20130925
008 201309s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc1309091
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAwad, Mark M
245 0 0 _aAcquired resistance to crizotinib from a mutation in CD74-ROS1.
_h[electronic resource]
260 _bThe New England journal of medicine
_c09 2013
300 _a1173 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdenocarcinoma
_xgenetics
650 0 4 _aDrug Resistance
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xgenetics
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProtein-Tyrosine Kinases
_xgenetics
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aPyrazoles
_xtherapeutic use
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aTranslocation, Genetic
700 1 _aEngelman, Jeffrey A
700 1 _aShaw, Alice T
773 0 _tThe New England journal of medicine
_gvol. 369
_gno. 12
_gp. 1173
856 4 0 _uhttps://doi.org/10.1056/NEJMc1309091
_zAvailable from publisher's website
999 _c23098849
_d23098849